417 healthcare jobs found in Wayne, PA

At Accendra Health, we understand that healthcare is complex, and we’re here to make it easier. We help deliver care beyond traditional settings, making essential products and services more accessible through every stage of life. As part of the care team, our teammates play a critical role in delivering personalized, long-term care for the patients we serve.   With deep expertise promoting health outside the hospital and a presence in communities nationwide through our Apria and Byram Healthcare brands, Accendra Health does more than just deliver the essentials.   If you’re interested in meaningful work with impact, explore our career opportunities ─- from remote-friendly to hybrid and in-person roles ─- and join us in our purpose of     Teammate Benefits As an Accendra Health employee, you have choices to fit your life. Our comprehensive benefits program is designed to meet you where you are — through all of life’s stages. We’ve got you and your family...

To be eligible for this position, you must reside in the same country where the job is located. This is a home-based remote role, that requires up to 30-40% travel. IQVIA's Commercial Compliance Solutions  IQVIA offers comprehensive commercial compliance solutions that integrate best-in-class strategic consulting, services, and technology. These solutions help organizations manage compliance processes efficiently, reduce risk, and drive business value. Key areas include compliance process design and optimization, tiering and payment managed services, fair market value, transparency reporting solutions, consent management, and provider/grant management insights. By leveraging IQVIA's Connected Intelligence™, organizations can ensure their compliance programs operate harmoniously and effectively. Job Overview  Provides domain expertise as a trusted advisor, for compliance experts. Primarily prospecting and problem solving to help clients evolve in a complex and dynamic...

Why work for IQVIA MedTech? IQVIA MedTech delivers solutions and services that support the needs of medical device companies and in vitro diagnostics organizations—from concept to patient. You’ll have the opportunity to grow your career while helping customers drive better human health outcomes. We actively invest in talent and empower our people with meaningful work and the ability to shape their professional path. Position Overview: IQVIA is seeking a dynamic Solution Sales Specialist to expand adoption of IQVIA’s de-identified health data helping Medical Device organizations unlock meaningful insights from their data. This role combines expertise in de-identified health data analytics, consultative selling , and MedTech commercial strategy .  You will focus on new business generation, pipeline growth and long-term client partnerships within the MedTech customer segment.  IQVIA’s de-identified health data solutions include not only custom reports and...

To be eligible for this position, you must reside in the same country where the job is located.  This role focuses on selling digital media measurement solutions to pharmaceutical clients by leveraging data-driven methodologies, consulting with clients, and driving business growth for IQVIA Digital in a rapidly evolving healthcare landscape. Job Overview We are seeking passionate measurement sellers with strong digital media expertise and hands‑on experience applying measurement methodologies to pharmaceutical use cases. You are a creative problem‑solver and trusted consultant who can translate complex analytical approaches into clear, outcomes‑driven recommendations for pharmaceutical clients and their agency partners . In this consultative and highly collaborative role, you will help leading life‑science brands navigate the rapidly evolving digital media landscape and understand what “best‑in‑class” measurement looks like. You will be responsible for developing...

The Large Pharma Segment Lead for the Tech Enabled Sales Organization leads strategic growth, client impact, and profitability across outsourced field and virtual sales teams supporting Key Accounts. This role is responsible for expanding client relationships, driving revenue and margin growth, and ensuring operational excellence across a diverse portfolio of healthcare-focused commercial solutions. Key Responsibilities: Client Relationship Management Oversee and expand the Key Account client portfolio, ensuring high satisfaction and retention. Maintain strong direct client engagement to build transformative partnerships that address critical business levers and deliver measurable impact. Revenue and Profit Growth Develop and execute strategies to drive revenue and profitability, emphasizing margin expansion and operational excellence. Team Leadership Lead Business Development and operational delivery teams responsible for selling and delivering Contract Sales...

Associate Director, Business Development - Medical & Scientific Communications JOB SUMMARY (Agency Equivalent Title = VP, New Business Development) IQVIA’s Health Communications Group unites specialized agencies to provide end‑to‑end communications rooted in science and scaled by creativity and technology. Our teams partner with clients across the product lifecycle—spanning Medical & Scientific Communications, Promotional Medical Education, Marketing & Advertising, and Medical Affairs. We are currently seeking an Associate Director of Business Development to join our team and contribute to continued growth within this division. The Associate Business Development Director, Medical & Scientific Communications is relied upon to drive revenue growth through identification, cultivation and closure of business opportunities with new and existing pharmaceutical and biotech accounts, actively manage sales targets and related activities to achieve sales goal....

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

At Globus Medical, we move with a sense of urgency to deliver innovations that improve the quality of life of patients with musculoskeletal disorders. Our team is inspired by the needs of these patients, and the surgeons and healthcare providers who treat them. We embrace a culture of exceptional response by partnering with researchers and educators to transform clinical insights into tangible solutions. Our solutions improve the techniques and outcomes of surgery so patients can resume their lives as quickly as possible.  Position Summary: The International Sales Operations Manager will play a critical role in driving the commercial success of our global medical device business. This individual will partner closely with regional sales leaders to enhance operational efficiency, improve data-driven decision making, and support revenue growth across our international hardware markets. The ideal candidate has deep experience in sales operations within the medical device or...

Position territory: Philadelphia North ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on for the prevention and treatment for HIV.  We go to extraordinary lengths to deliver the sorts of breakthroughs, both in prevention, treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care.  We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV Healthcare has played a significant part in delivering breakthroughs that have turned HIV...

Inizio Engage has a long-standing partnership with a leading pharmaceutical company that is dedicated to bringing innovative products and effective results to physicians and patients. We are seeking performance-driven candidates who bring documented sales success and can make an impact quickly within your assigned territory.  The Rare Disease Pharmaceutical Sales Representative will achieve activity metrics, help to drive sales for a rare disease product, and must meet all relevant standards as set by Inizio and the client. This is your opportunity to join Inizio Engage and represent a top biotechnology company! What’s in it for you? Competitive compensation   Excellent Benefits – accrued time off, medical, dental, vision, 401k, disability & life insurance, paid maternity and paternity leave benefits, employee discounts/promotions Employee discounts & exclusive promotions Recognition programs, contests, and company-wide awards Exceptional, collaborative...